CFDA: Yet another story? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-12 11:09 (1143 d 16:14 ago) – Posting: # 18887
Views: 4,787

Hi Helmut,

thanks for your help.

CFDA has relased the draft guidance for HVBE, which follows FDA method (RSABE).

I still have a question about EMA method. Do you mean if we follow EMA's guidance, the ABEL should be used rather than RSABE, please give me more advise.

thanks in advance. :-D:-D:-D

Complete thread:

Activity
 Admin contact
21,592 posts in 4,514 threads, 1,532 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Friday 03:24 CEST (Europe/Vienna)

It is a capital mistake to theorise before one has data.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5